Literature DB >> 7587003

Insulin increases renal magnesium excretion: a possible cause of magnesium depletion in hyperinsulinaemic states.

M S Djurhuus1, P Skøtt, O Hother-Nielson, N A Klitgaard, H Beck-Nielsen.   

Abstract

The effects of insulin upon renal magnesium excretion were examined. Urinary magnesium excretion rates were measured in seven healthy volunteers (three men, four women) before and during a euglycaemic, hyperinsulinaemic clamp. Insulin was infused at 120 pmol m-2 min-1 and at 240 pmol m-2 min-1. Compared to baseline, the renal magnesium excretion increased 30% during the infusion of insulin at a rate of 120 pmol m-2 min-1. During infusion of insulin, 240 pmol m-2 min-1, renal magnesium excretion increased 50% compared to baseline. There were no changes in either glomerular filtration rates, plasma magnesium, urinary volume or general changes in the renal handling of divalent ions as judged by an unchanged urinary excretion rate of calcium (0% during infusion of insulin, 120 pmol m-2 min-1, and 8% increase during infusion of 240 pmol m-2 min-1 (NS). During the 120 pmol m-2 min-1 insulin infusion rate, plasma insulin rose from 46.1 pmol I-1 to 158.8 pmol I-1 and during the 240 pmol m-2 min-1 insulin infusion rate, mean plasma insulin concentration was 361.4 pmol I-1. Thus, physiological concentrations of insulin induce a specific increase in the renal excretion of magnesium. This might partly explain the magnesium depletion observed in various hyperinsulinaemic states, diabetes mellitus, atherosclerosis, hypertension, and obesity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7587003     DOI: 10.1111/j.1464-5491.1995.tb00566.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  12 in total

1.  Dietary fat, saturated fatty acid, and monounsaturated fatty acid intakes and risk of bone fracture: a systematic review and meta-analysis of observational studies.

Authors:  H Mozaffari; K Djafarian; M D Mofrad; S Shab-Bidar
Journal:  Osteoporos Int       Date:  2018-06-12       Impact factor: 4.507

2.  Association of magnesium in serum and urine with carotid intima-media thickness and serum lipids in middle-aged and elderly Chinese: a community-based cross-sectional study.

Authors:  Yi Cao; Cheng Wang; Ke Guan; Ying Xu; Yi-xiang Su; Yu-ming Chen
Journal:  Eur J Nutr       Date:  2015-03-07       Impact factor: 5.614

3.  Prader-Willi syndrome, deletion subtypes, and magnesium: Potential impact on clinical findings.

Authors:  Merlin G Butler; Neil Cowen; Anish Bhatnagar
Journal:  Am J Med Genet A       Date:  2022-08-06       Impact factor: 2.578

Review 4.  Magnesium and type 2 diabetes.

Authors:  Mario Barbagallo; Ligia J Dominguez
Journal:  World J Diabetes       Date:  2015-08-25

5.  Dysregulated Erythroid Mg2+ Efflux in Type 2 Diabetes.

Authors:  Ana Ferreira; Alicia Rivera; Jay G Wohlgemuth; Jeffrey S Dlott; L Michael Snyder; Seth L Alper; Jose R Romero
Journal:  Front Cell Dev Biol       Date:  2022-04-04

6.  The relationship between hypomagnesemia, metformin therapy and cardiovascular disease complicating type 2 diabetes: the Fremantle Diabetes Study.

Authors:  Kirsten E Peters; S A Paul Chubb; Wendy A Davis; Timothy M E Davis
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

Review 7.  Metabolic syndrome: is equine disease comparable to what we know in humans?

Authors:  Antonia Ertelt; Ann-Kristin Barton; Robert R Schmitz; Heidrun Gehlen
Journal:  Endocr Connect       Date:  2014-06-03       Impact factor: 3.335

Review 8.  Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis.

Authors:  James J DiNicolantonio; James H O'Keefe; William Wilson
Journal:  Open Heart       Date:  2018-01-13

Review 9.  Magnesium in Prevention and Therapy.

Authors:  Uwe Gröber; Joachim Schmidt; Klaus Kisters
Journal:  Nutrients       Date:  2015-09-23       Impact factor: 5.717

10.  Association between serum magnesium concentration and metabolic syndrome, diabetes, hypertension and hyperuricaemia in knee osteoarthritis: a cross-sectional study in Hunan Province, China.

Authors:  Yilun Wang; Jie Wei; Chao Zeng; Tuo Yang; Hui Li; Yang Cui; Dongxing Xie; Bei Xu; Zhichen Liu; Jiatian Li; Shide Jiang; Guanghua Lei
Journal:  BMJ Open       Date:  2018-09-10       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.